Anna M Mandalakas Selected Research

Rifampin (Rifampicin)

1/2023	Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
1/2022	Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.
1/2020	Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
6/2015	Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna M Mandalakas Research Topics

Disease

34	Tuberculosis (Tuberculoses) 12/2023 - 03/2009
12	Infections 01/2022 - 09/2012
5	Pulmonary Tuberculosis 01/2022 - 01/2013
4	Latent Infection 10/2023 - 01/2013
2	Lymph Node Tuberculosis (Scrofula) 01/2022 - 01/2020
2	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2022 - 01/2020
2	Disease Progression 06/2021 - 10/2018
1	Vaccine-Preventable Diseases 01/2022
1	Bovine Tuberculosis 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Extrapulmonary Tuberculosis 01/2019
1	Malnutrition (Nutritional Deficiencies) 03/2013
1	Cicatrix (Scar) 09/2012
1	Ascariasis 09/2012
1	Latent Tuberculosis 10/2008
1	West Nile Fever 05/2007

Drug/Important Bio-Agent (IBA)

8	Tuberculin (PPD)IBA 01/2022 - 10/2008
6	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 03/2009
4	VaccinesIBA 10/2023 - 01/2016
4	Rifampin (Rifampicin)FDA LinkGeneric 01/2023 - 06/2015
4	Isoniazid (Ftivazide)FDA LinkGeneric 10/2018 - 09/2012
3	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2023 - 11/2020
3	GoldIBA 01/2019 - 03/2013
3	AntigensIBA 11/2017 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2018
2	InterferonsIBA 01/2016 - 03/2013
1	bedaquiline (R207910)IBA 12/2023
1	CytokinesIBA 01/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Attenuated VaccinesIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013
1	Immunoglobulin E (IgE)IBA 09/2012
1	PesticidesIBA 05/2007

Therapy/Procedure

16	Therapeutics 01/2023 - 01/2013
2	Duration of Therapy 12/2021 - 01/2021
1	Precision Medicine 06/2021
1	Art Therapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2016
1	Ambulatory Care (Outpatient Care) 03/2013